KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nutanix (NTNX) Research & Development (2016 - 2026)

Nutanix (NTNX) has disclosed Research & Development for 12 consecutive years, with $202.3 million as the latest value for Q1 2026.

  • On a quarterly basis, Research & Development rose 10.65% to $202.3 million in Q1 2026 year-over-year; TTM through Jan 2026 was $769.8 million, a 12.65% increase, with the full-year FY2025 number at $736.8 million, up 15.31% from a year prior.
  • Research & Development was $202.3 million for Q1 2026 at Nutanix, up from $187.5 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $202.3 million in Q1 2026 to a low of $141.9 million in Q1 2022.
  • A 5-year average of $163.2 million and a median of $159.2 million in 2024 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: decreased 1.78% in 2022, then increased 17.08% in 2025.
  • Nutanix's Research & Development stood at $149.4 million in 2022, then rose by 1.69% to $152.0 million in 2023, then rose by 14.47% to $174.0 million in 2024, then increased by 7.77% to $187.5 million in 2025, then grew by 7.88% to $202.3 million in 2026.
  • Per Business Quant, the three most recent readings for NTNX's Research & Development are $202.3 million (Q1 2026), $187.5 million (Q4 2025), and $193.7 million (Q3 2025).